Iran’s Health Ministry in a statement announced the country’s daily COVID-19 fatalities and cases stood at 76 and 3,839, respectively from Wednesday to Thursday.
According to the ministry, the total COVID-19 death toll and cases since the beginning of the outbreak in the country in late February 2020 stand at 129,988 and 6,125,596.
It said 3,314 patients are in critical condition, and 623 new ones have been hospitalized.
According to the statement, 5,901,532 people have so far either recovered from the disease or have been discharged from hospitals, and 38,983,988 diagnostic tests have so far been carried out in the country.
No city in the country is currently coded red (very high-risk) in terms of the coronavirus spread, while 22 cities are in the orange zone (high-risk) and the number of yellow (medium-risk) and blue (low-risk) cities are 207 and 219, respectively.
Since the outbreak, Iran has grappled with five waves of COVID-19 infections, one greater and deadlier than another.
Until a few weeks ago, the country was grappling with a fifth wave of COVID-19 infections, mainly sparked by the Delta variant, seeing record high daily deaths and cases of over 700 and 40,000, respectively. Although the fifth wave has subsided thanks to the increased pace of the public vaccination process, authorities constantly warn against the start of a new wave given the spread of the new strain of the coronavirus, known as Omicron, calling for full compliance with the health protocols.
Iran’s public vaccination has gained greater momentum over the past few months on the back of a rise in imports and domestic production. The country has produced a number of COVID jabs domestically and received several COVID-19 vaccine batches from Russia (Sputnik V), China (Sinopharm), Japan (AstraZeneca) and India (COVAXIN).
According to the ministry’s Thursday statement, 106,621,650 doses of COVID jabs have so far been administered in Iran, of which 57,867,860 have been given to people as the first dose, and 47,608,297 as the second dose.
In addition, 1,145,493 people have received their third dose.